Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-43,038
Closed -$629K 173
2026
Q1
$629K Sell
43,038
-47,900
-53% -$703K 0.17% 145
2025
Q4
$1.15M Buy
90,938
+10,038
+12% +$148K 0.3% 97
2025
Q3
$1.24M Buy
80,900
+3,800
+5% +$61.3K 0.31% 106
2025
Q2
$1.21M Buy
77,100
+8,700
+13% +$132K 0.45% 91
2025
Q1
$1.31M Buy
68,400
+12,200
+22% +$267K 0.5% 90
2024
Q4
$1.34M Buy
56,200
+10,200
+22% +$285K 0.5% 85
2024
Q3
$1.29M Buy
+46,000
New +$1.3M 0.44% 95
2023
Q4
Sell
-40,683
Closed -$803K 143
2023
Q3
$803K Buy
40,683
+7,300
+22% +$144K 0.37% 68
2023
Q2
$757K Buy
+33,383
New +$672K 0.35% 75

Other funds holding RXO

HighVista Strategies's RXO Position: Q2 2026 in Review

HighVista Strategies sold out of RXO (RXO) in Q2 2026, closing a stake of 43,038 shares — an estimated $629K sold.

HighVista Strategies first reported a position in RXO in Q2 2023 and held it in 9 quarters. The position peaked at $1.34M in Q4 2024. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • HighVista Strategies reported no remaining RXO position as of Q2 2026 after selling out during the quarter.
  • HighVista Strategies sold 43,038 RXO shares in Q2 2026, an estimated $629K.
  • HighVista Strategies first reported a position in RXO in Q2 2023 and held it in 9 quarters.
  • HighVista Strategies's RXO position peaked at $1.34M in Q4 2024.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on HighVista Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.